COMP <GO>
ORCL vs PLTR // EV/EBITDA & P/E VALUATION
Oracle Corporation (NYSE) VS. Palantir Technologies Inc. (NASDAQ) • 15-METRIC TALLY: ORCL 4
— PLTR 10
▲ EV/EBITDA & P/E VALUATION LEADER: ORCL
LAST: $130.67 (-6.37%) • MKT CAP: $421.99B
valuation
17.5x
LAST: $184.11 (-6.27%) • MKT CAP: $471.81B
valuation
157.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORCL VS. PLTR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ORCL | PLTR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 84.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.39% | 26.88% | -15.49 | PLTR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.5x | 157.6x | -140.03 | ORCL | /valuation <GO> |
| Free Cash Flow Yield | -7.27% | 0.76% | -8.03 | PLTR | /fcf-yield <GO> |
| Operating Margin | 32.12% | 42.80% | -10.68 | PLTR | /operating-margins <GO> |
| Net Profit Margin | 26.36% | 49.00% | -22.64 | PLTR | /net-margins <GO> |
| Revenue Growth (YoY) | 21.62% | 78.92% | -57.30 | PLTR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.53% | 0.00% | +1.53 | ORCL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.52 | 17.06 | -15.54 | PLTR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | PLTR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 11.57% | 14.35% | -2.78 | ORCL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 59.2 | -13.70 | PLTR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.37 | 2.17 | -0.80 | PLTR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.0x | 83.7x | -69.72 | ORCL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $421.99B | $471.81B | -$49.82B | PLTR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ORCL REV | PLTR REV | ORCL GROSS % | PLTR GROSS % | ORCL FCF | PLTR FCF |
|---|---|---|---|---|---|---|
| FY 2026 | $67.36B | — | — | — | -$23.69B | — |
| FY 2025 | $57.40B | $4.48B | — | 82.4% | -$394.0M | $2.10B |
| FY 2024 | $52.96B | $2.87B | — | 80.3% | $11.81B | $1.14B |
| FY 2023 | $49.95B | $2.23B | — | 80.6% | $8.47B | $697.1M |
| FY 2022 | $42.44B | $1.91B | — | 78.6% | $5.03B | $183.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORCL // BETA 1.37
PLTR // BETA 2.17